Long-term quality of life and clinical outcomes in patients with resistant hypertension treated with renal denervation

Agata Krawczyk-Ożóg; Tomasz Tokarek; Katarzyna Moczała; Zbigniew Siudak; Artur Dziewierz; Waldemar Mielecki; Tomasz Górecki; Karolina Gerba; Dariusz Dudek

doi:10.5114/aic.2016.63633

eISSN: 1897-4295
ISSN: 1734-9338

Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2016
vol. 12

Send email

Copy url:

abstract:

Original paper

Long-term quality of life and clinical outcomes in patients with resistant hypertension treated with renal denervation

Agata Krawczyk-Ożóg

,

Tomasz Tokarek

,

Katarzyna Moczała

,

Zbigniew Siudak

,

Artur Dziewierz

,

Waldemar Mielecki

,

Tomasz Górecki

,

Karolina Gerba

,

Dariusz Dudek

Adv Interv Cardiol 2016; 12, 4 (46): 329–333

DOI: https://doi.org/10.5114/aic.2016.63633

Online publish date: 2016/11/17

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Krawczyk-Ożóg A, Tokarek T, Moczała K, et al. Long-term quality of life and clinical outcomes in patients with resistant hypertension treated with renal denervation. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2016;12(4):329-333. doi:10.5114/aic.2016.63633.

APA

Krawczyk-Ożóg, A., Tokarek, T., Moczała, K., Siudak, Z., Dziewierz, A.,  & Mielecki, W. et al. (2016). Long-term quality of life and clinical outcomes in patients with resistant hypertension treated with renal denervation. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 12(4), 329-333. https://doi.org/10.5114/aic.2016.63633

Chicago

Krawczyk-Ożóg, Agata, Tomasz Tokarek, Katarzyna Moczała, Zbigniew Siudak, Artur Dziewierz, Waldemar Mielecki,  and Tomasz Górecki et al. 2016. "Long-term quality of life and clinical outcomes in patients with resistant hypertension treated with renal denervation". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 12 (4): 329-333. doi:10.5114/aic.2016.63633.

Harvard

Krawczyk-Ożóg, A., Tokarek, T., Moczała, K., Siudak, Z., Dziewierz, A., Mielecki, W., Górecki, T., Gerba, K.,  and Dudek, D. (2016). Long-term quality of life and clinical outcomes in patients with resistant hypertension treated with renal denervation. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 12(4), pp.329-333. https://doi.org/10.5114/aic.2016.63633

MLA

Krawczyk-Ożóg, Agata et al. "Long-term quality of life and clinical outcomes in patients with resistant hypertension treated with renal denervation." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 12, no. 4, 2016, pp. 329-333. doi:10.5114/aic.2016.63633.

Vancouver

Krawczyk-Ożóg A, Tokarek T, Moczała K, Siudak Z, Dziewierz A, Mielecki W et al. Long-term quality of life and clinical outcomes in patients with resistant hypertension treated with renal denervation. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2016;12(4):329-333. doi:10.5114/aic.2016.63633.

Introduction: Pharmacological treatment combined with lifestyle modifications is an effective treatment for arterial hypertension. However, there are still patients who do not respond to standard treatments. Patients with pharmacologically resistant hypertension may benefit from renal denervation (RDN).

Aim: To assess long-term quality of life (QoL) after RDN and effectiveness in reduction of blood pressure (BP) in patients with resistant hypertension.

Material and methods: From 2011 to 2014, 12 patients with previously diagnosed resistant hypertension, treated by RDN, were included in this study. The QoL was assessed using a standardized Polish version of the Nottingham Health Profile questionnaire (NHP).

Results: The median age was 54 (IQR: 51–57.5) years. Mean baseline ambulatory pre-procedural systolic/diastolic BP was 188/115 ±29.7/18 mm Hg. The mean values of systolic/diastolic BP measured perioperatively and 3, 6, 12 and 24 months postoperatively were 138/86, 138/85, 146/82, 152/86, and 157/91. All p-values for mean systolic and diastolic BP before versus successive time points after RDN were statistically significant; p-value for all comparisons < 0.05. Improvement of QoL was only observed in two sections of the NHP questionnaire: emotional reaction and sleep disturbance. The analysis of the NHP index of Distress (NHP-D) showed a lower distress level perioperatively and 3, 6, 12 and 24 months after RDN as compared to baseline. The RDN was not associated with any significant adverse events.

Conclusions: Patients with pharmacologically resistant hypertension treated with RDN achieved significant reduction in BP during 24-month follow-up. Furthermore, a significant improvement in the QoL was observed in those patients.

keywords:

Long-term quality of life and clinical outcomes in patients with resistant hypertension treated with renal denervation

Agata Krawczyk-Ożóg , Tomasz Tokarek , Katarzyna Moczała , Zbigniew Siudak , Artur Dziewierz , Waldemar Mielecki , Tomasz Górecki , Karolina Gerba , Dariusz Dudek

resistant hypertension, blood pressure, quality of life, catheter-based renal denervation

Agata Krawczyk-Ożóg

,

Tomasz Tokarek

,

Katarzyna Moczała

,

Zbigniew Siudak

,

Artur Dziewierz

,

Waldemar Mielecki

,

Tomasz Górecki

,

Karolina Gerba

,

Dariusz Dudek